NCT02965976 2023-02-16
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Roswell Park Cancer Institute
Phase 2 Completed
Roswell Park Cancer Institute
Norwegian University of Science and Technology
Mayo Clinic
St. Olavs Hospital
Centre hospitalier de l'Université de Montréal (CHUM)
National Institutes of Health Clinical Center (CC)
Georgetown University
University of Colorado, Denver